Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Mannucci

Showing results (1-10 of 376) with videos related to

Pageof 38
Sort By:
Giornale Italiano Di Cardiologia (2006)|December 22, 2012
[Incretin-based therapies and cardiovascular outcome: analyses, pooled analyses and meta-analyses]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 1, 2016
[Anti-diabetic therapy and cardiovascular disease]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 22, 2012
[New drugs for type 2 diabetes: expanding cardiovascular protection beyond type 2 diabetes?]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 1, 2016
[Cardiovascular effects of insulin therapy: from pharmacology to clinical trials]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|March 3, 2011
[Glucagon-like peptide-1 analogues and cardiovascular risk factors: evidence from clinical trials]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 24, 2013
[Anti-diabetic therapy and cardiovascular risk: the opportunity of incretin-based therapies. Introduction]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|February 3, 2017
[Results of the LEADER study: current evidence and perspectives in research]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|January 28, 2015
[Anti-diabetic therapy and cardiovascular risk]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 14, 2011
[Beyond glycemic control in type 2 diabetes. Promises and gambles of therapy with glucagon-like peptide-1 receptor agonists]Edoardo Mannucci
ISRN Endocrinology|December 5, 2012
Insulin therapy and cancer in type 2 diabetesEdoardo Mannucci
Pageof 38

Showing results (1-10 of 376) with videos related to

Sort By:
Pageof 38
Giornale Italiano Di Cardiologia (2006)|December 22, 2012
[Incretin-based therapies and cardiovascular outcome: analyses, pooled analyses and meta-analyses]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 1, 2016
[Anti-diabetic therapy and cardiovascular disease]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 22, 2012
[New drugs for type 2 diabetes: expanding cardiovascular protection beyond type 2 diabetes?]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|April 1, 2016
[Cardiovascular effects of insulin therapy: from pharmacology to clinical trials]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|March 3, 2011
[Glucagon-like peptide-1 analogues and cardiovascular risk factors: evidence from clinical trials]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 24, 2013
[Anti-diabetic therapy and cardiovascular risk: the opportunity of incretin-based therapies. Introduction]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|February 3, 2017
[Results of the LEADER study: current evidence and perspectives in research]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|January 28, 2015
[Anti-diabetic therapy and cardiovascular risk]Edoardo Mannucci
Giornale Italiano Di Cardiologia (2006)|December 14, 2011
[Beyond glycemic control in type 2 diabetes. Promises and gambles of therapy with glucagon-like peptide-1 receptor agonists]Edoardo Mannucci
ISRN Endocrinology|December 5, 2012
Insulin therapy and cancer in type 2 diabetesEdoardo Mannucci
Pageof 38